U.S. Attorney Announces First Settlement Involving Psychiatric Residential Treatment Facilities in connection with billing of the Medicaid program for servies to children and adolescents in 2005 at Southwood's three Psychiatric Residential Treatment Facilities (PRTFs):
AstraZeneca Pays $520 Million
AstraZeneca has agreed to pay $520 million in civil fines, penalties and damages to settle allegations that the company defrauded Medicare, Medicaid and other government-funded programs in connection with its marketing and promotional practices for the blockbuster atypical antipsychotic Seroquel.
Pfizer Pays $2 Billion Settlement
Pfizer, Inc. has agreed to plead guilty to criminal conduct and to pay more than $2 billion in criminal and civil fines, penalties and damages to settle allegations made in multiple whistleblower lawsuits that the pharmaceutical giant defrauded Medicare, Medicaid and other government-funded health care programs
U.S. Attorney Announces First Settlement Involving Psychiatric Residential Treatment Facilities
Fatal Overdoses Were Fueled By Prescription Drugs
A Sugared Pill
By Andrew Jack
The Financial Times
Published March 8, 2011